Clinical Trials Logo

Contraception clinical trials

View clinical trials related to Contraception.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06307353 Not yet recruiting - Contraception Clinical Trials

Trends of Contraception Methods in Urban Medical Center in el_Balyana

Start date: March 1, 2024
Phase:
Study type: Observational

family planning is avital primary Health care intervention that saves lives of mothers and infants empowers women and support their choices regarding their health public life and additional education .In addition family planning is considered as a short term intervention to limit population growth and manage overpopulation problems.Globally the contraception prevalance rate an indicator for family planning programs continue to face challenges in developing countries.

NCT ID: NCT06299475 Not yet recruiting - Contraception Clinical Trials

Structured Online Contraceptive Counseling (LOWE Trial) at Emergency Contraception (EC) Pharmacy Provision LOWE+EC=LOWEC

LOWEC
Start date: March 2024
Phase: N/A
Study type: Interventional

To increase sexual and reproductive health and rights through the improvement of contraceptive counseling and easy access to service and, thus, women's use of effective contraceptives after purchase of an emergency contraceptive pill (ECP).

NCT ID: NCT06296797 Not yet recruiting - Contraception Clinical Trials

Patient-centered Information on Permanent Contraception

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to understand whether providing information to women with a strong desire to avoid future pregnancy about how tubal sterilization compares to long-acting reversible contraceptives improves perceived access to available contraceptives. Participants will: - Complete a baseline survey - Receive access to web-based educational resources - Complete a brief follow up survey immediately after exploring these web-based resources - Complete a follow-up survey 3 months after enrolling The investigators will compare outcomes among participants provided with access to a new website (intervention) summarizing recent patient-centered outcomes research (PCOR) comparing interval laparoscopic tubal sterilization and long-acting reversible contraception (LARC) to control participants provided with access to the existing Planned Parenthood website on tubal sterilization.

NCT ID: NCT06230770 Not yet recruiting - Contraception Clinical Trials

Impact of Progestin-only Contraception on Bleeding Patterns in Individuals Initiating GATT

Start date: February 1, 2024
Phase:
Study type: Observational

Gender diverse individuals who use gender-affirming testosterone therapy (GATT) to reduce gender dysphoria may also use progestins for contraception and to manage or suppress uterine bleeding. Research is limited, however, regarding expected bleeding patterns for individuals who choose to initiate GATT concurrently with a progestin. Clinicians who prescribe GATT do not have sufficient data to adequately counsel patients on side effects of concurrent progestin use and therefore extrapolate from studies conducted in cisgender women. This study is a prospective cohort study evaluating bleeding patterns and satisfaction among patients initiating GATT with or without concurrent initiation of a progestin contraceptive. The results from this study will enable clinicians to more accurately counsel patients using GATT on how the use of a progestin might affect their bleeding and whether this differs by progestin method.

NCT ID: NCT06186271 Not yet recruiting - Contraception Clinical Trials

International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS)

INAS-SEECS
Start date: January 2024
Phase:
Study type: Observational

The combined oral contraceptive (COC) containing estetrol (E4) and drospirenone (DRSP) (E4/DRSP) is a novel oral contraceptive containing a fixed dose of E4 (14.2 mg) and DRSP (3 mg). The proposed study will address post-market requirements for E4/DRSP under section 505(o) in response to the Food and Drug Administration (FDA) request. The primary objective of the study is to characterize and compare the risks of E4/DRSP with EE/DRSP and E4/DRSP with a pooled cohort of users of EE/LNG, EE/NETA, and EE/NGM combinations (non-DRSP-containing COCs) in a study population of actual users of these preparations under routine clinical practice. The main clinical outcome of interest is VTE.

NCT ID: NCT06081842 Not yet recruiting - Contraception Clinical Trials

Strengthening Contraceptive Counseling Services: Research Protocol for a Multi-phase Complex Intervention in Pakistan and Nigeria

Start date: November 2023
Phase: N/A
Study type: Interventional

High-quality contraceptive counseling can strengthen global efforts to reduce the unmet need for and suboptimal use of modern contraceptives. This study aims to identify a package of contraceptive counseling interventions for Pakistan and Nigeria designed to strengthen existing contraceptive services and determine its effectiveness in increasing clients' level of decision-making autonomy and meeting their contraceptive needs.

NCT ID: NCT05988983 Not yet recruiting - Contraception Clinical Trials

The Over The Counter Pill National Study

Start date: November 2023
Phase:
Study type: Observational

This is a prospective cohort study of individuals purchasing the oral contraceptive pill over the counter (OTC) in pharmacies in 32 US states. The comparison group is people receiving a prescription (Rx) for oral contraception. Both groups will be followed for one year to examine contraceptive continuation rates. This study will also identify who is using the pill OTC and why and evaluate differences in pregnancy intention and measures of contraceptive agency between the two groups.

NCT ID: NCT05910580 Not yet recruiting - Pregnancy Clinical Trials

Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the effectiveness of evidence-based Screening, Brief Intervention, and Referral to Treatment (SBIRT) among adult patients who screen positive to one or more risky alcohol or substance use behaviors while seeking care at a sexual and reproductive health (SRH) clinic. The main questions it aims to answer are: - Does SBIRT impact patients' alcohol and substance use, SRH, mental health, physical health, quality of life, and wellbeing? - Does SBIRT effectiveness differ by ethnicity, socioeconomic status, age, gender, and urbanicity? - Does SBIRT effectiveness differ by delivery mode (in-person vs. telemedicine)? Participants will receive in-person SBIRT, telemedicine SBIRT, or usual care. Participants will complete surveys at interviews at baseline, 30 days, and 3 months. Researchers will compare patients who received SBIRT to patients who receive usual care to see if patients who receive the SBIRT intervention have a greater reduction in negative outcomes as compared to those who receive usual care. In this setting, usual care consists of basic quantity and frequency questions asked inconsistently as part of the admission process and varying by provider, with no standardized approach to screening, treatment, follow-up, or referral.

NCT ID: NCT05909410 Not yet recruiting - Contraception Clinical Trials

Perception About Benefits and Risks Related to Combined Hormonal Contraceptives Use in Patients With Lynch Syndrome

Start date: July 1, 2023
Phase:
Study type: Observational

Combined hormonal contraceptives (CHCs), according to the opinion by The Manchester International Consensus Group, should be considered for women wishing contraception because also positively impact endometrial cancer and ovarian cancer risk. The awareness of the effects of hormonal therapies in women at high risk of developing endometrial cancer, colorectal, breast, or ovarian cancer, such as those affected by Lynch syndrome (LS), is currently limited, with few published studies addressing these populations. Making informed decisions about CHC use in this context necessitates careful consideration of individual cancer risk and the potential benefits and risks associated with CHC use. Accurate information regarding the oncological risks associated with CHC use is essential for facilitating shared decision-making between women and their healthcare providers in this patient population. This prospective study aims to evaluate the knowledge, attitudes, and beliefs of women with LS concerning CHCs and their potential effects on specific disease development and cancer risk, comparing them to the general population. By considering psychosocial factors and individual perceptions of cancer risk, this study seeks to contribute to informed decision-making, personalized counseling, and improved strategies for gynecologic cancer risk management in women with LS.

NCT ID: NCT05904405 Not yet recruiting - Contraception Clinical Trials

Perceived Quality of Family Planning Counselling

Start date: July 2023
Phase:
Study type: Observational [Patient Registry]

The goal of this cross sectional study is to test Perceived quality of family planning counseling and its determinants among females in reproductive age in El-Dakhla District, New Valley government ,Egypt. The main question[s] it aims to answer are: 1. During the contraception consultation, I was able to give my opinion about what I needed. 2. I received complete information about my options for contraceptive methods. 3. The provider knew how to explain contraception clearly. 4. I had the opportunity to participate in the selection of a method. 5. I received information about how to protect myself from sexually transmitted infections. 6. I received information about what to do if a method fails (e.g., broken condom, forget a pill, feel an IUD is poorly placed). 7. I could understand how my body might react to using contraception. 8. I could understand how to use the method(s) we talked about during the consultation. 9. I received information about what to do if I wanted to stop using a method. 10. The provider explained to me what to do if I had a reaction to a method (e.g., allergies, nausea, pains, menstrual changes). 11. I felt the information I shared with the provider was going to stay between us. 12. The provider gave me the time I needed to consider the contraceptive options we discussed. 13. The provider was friendly during the contraception consultation. 14. I felt the health care provider had sufficient knowledge about contraceptive methods. 15. The provider showed interest in my health while we talked about contraception. 16. The provider was interested in my opinions. 17. I felt listened to by the provider 18. The provider pressured me to use the method they wanted me to use. 19. I felt the provider treated me poorly because they tend to judge people. 20. I felt scolded because of my age. 21. The provider made me feel uncomfortable because of my sex life (e.g., when I started having sex, my sexual preferences, the number of partners I have, the number of children I have). 22. The provider looked at me or touched me in a way that made me feel uncomfortable.